Altis
4 known investors
Find your way into Altis
Sign up to see every warm intro you have to Altis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Altis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Altis provides independent, IC-grade investment diligence and market research on private companies from Seed to Series D+, working outside-in without access to management or data rooms. It serves venture capital and growth investors, publishing research reports and market landscapes on sectors such as industrial robotics and insurtech.
Investors · 4
How we know: Primary Venture Partners's portfolio page · Not right? Tell us
How we know: debiopharm.com · Not right? Tell us
How we know: latamlist.com · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseed financingJun 2023
Benchstrength (lead), Debiopharm Innovation Fund (lead)
Source ↗ - Undisclosed amountSeed Funding RoundApr 2022Source ↗
- Undisclosed amountSeed FundingFeb 2022Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Altis do?
- Altis provides independent, IC-grade investment diligence and market research on private companies from Seed to Series D+, working outside-in without access to management or data rooms. It serves venture capital and growth investors, publishing research reports and market landscapes on sectors such as industrial robotics and insurtech.
- Who are Altis's investors?
- Altis's investors include Primary Venture Partners, Benchstrength Partners, Debiopharm Innovation Fund, Galapagos Capital.

